Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of If blockade on orthostatic tolerance and sympathetic activity in healthy subjects
2007-006438-33Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ivabradine, metoprolol and reboxetine in orthostatic intolerance and postural orthostatic tachycardia syndrome (POTS) (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Change in heart rate at upright position after 20 minutes of passive orthostatism. Started Apr 2008; status: completed.
02
Drugs
ivabradinemetoprololreboxetine
03
Conditions
orthostatic intolerancepostural orthostatic tachycardia syndrome (POTS)
Beyond the preview
Go deeper on 2007-006438-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006438-33.